Home Journal Club	FAQ My Amedeo About Tranquillis Services	Flying Publisher
	The Word Brain - A Short Guide to Fast Language Learning - Free PDF: English, German, Italian

Hepatitis C

Free Subscription Articles published in J Hepatol Retrieve available abstracts of 166 articles: HTML format Text format

Single Articles

June 2010
1. GOWANS EJ , Roberts S, Jones K, Dinatale I, et al
   A phase I clinical trial of dendritic cell immunotherapy in HCV-infected individuals.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
2. FOERESTER K , Helmy A, Zhu Y, Khattar R, et al
   The novel immunoregulatory molecule FGL2: A potential biomarker for severity of chronic hepatitis C virus infection.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
3. CHENG WS , Roberts SK, McCaughan G, Sievert W, et al
   Low virological response and high relapse rates in hepatitis C genotype 1 patients with advanced fibrosis despite adequate therapeutic dosing.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
4. ROOMER R , Hansen BE, Janssen HL, de Knegt RJ, et al
   Thrombocytopenia and the risk of bleeding during treatment with peginterferon alfa and ribavirin for chronic hepatitis C.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
5. BARTENSCHLAGER R , Cosset FL, Lohmann V
   Hepatitis C virus replication cycle.
   J Hepatol. 2010.
   PubMed     Text format     Related articles   
   
   
   May 2010
6. ABE H , Ochi H, Maekawa T, Hayes CN, et al
   A common variation of IL28 affects gamma-GTP levels and inflammation of the liver in chronically infected hepatitis C virus patients.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
7. SUTTI S , Vidali M, Mombello C, Sartori M, et al
   Breaking self-tolerance toward cytochrome P4502E1 (CYP2E1) in chronic hepatitis C: Possible role for molecular mimicry.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
8. DAHARI H , Affonso de Araujo ES, Haagmans BL, Layden TJ, et al
   Pharmacodynamics of PEG-IFN-alpha-2a in HIV/HCV co-infected patients: Implications for treatment outcomes.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
9. SETO WK , Lai CL, Fung J, Hung I, et al
   Natural history of chronic hepatitis C: Genotype 1 versus genotype 6.
   J Hepatol. 2010.
   PubMed     Text format     Related articles    Abstract available
   
   
   
10. MIYAGI T , Takehara T, Nishio K, Shimizu S, et al
    Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
11. JOHN-BAPTISTE A , Krahn M, Heathcote J, Laporte A, et al
    The natural history of hepatitis C infection acquired through injection drug use: Meta-analysis and meta-regression.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2010
12. ZEISEL MB , Turek M, Baumert TF
    Getting closer to the patient: Upgrade of hepatitis C virus infection in primary human hepatocytes.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
13. CACOUB P , Halfon P, Rosenthal E, Bailly F, et al
    Care of hepatitis C virus infection in human immunodeficiency virus-infected patients: Modifications in three consecutive large surveys between 2004 and 2009.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
14. HOARE M , Gelson WT, Das A, Fletcher JM, et al
    CD4+ T-lymphocyte telomere length is related to fibrosis stage, clinical outcome and treatment response in chronic hepatitis C virus infection.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
15. STURM N , Thelu MA, Camous X, Dimitrov G, et al
    Characterization and role of intra-hepatic regulatory T cells in chronic hepatitis C pathogenesis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
16. CALES P , Halfon P, Batisse D, Carrat F, et al
    Comparison of liver fibrosis blood tests developed for HCV with new specific tests in HIV/HCV co-infection.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
17. SHOUVAL D
    Hospital related morbidity from chronic hepatitis C virus (HCV) infection in Australia and mortality from HCV infection in a population cohort in Denmark: Two complementary studies relevant to counseling patients.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
18. GIDDING HF , Amin J, Dore GJ, Ward K, et al
    Hospital-related morbidity in people notified with hepatitis C: A population-based record linkage study in New South Wales, Australia.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
19. CHATTERJI U , Lim P, Bobardt MD, Wieland S, et al
    HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2010
20. OMLAND LH , Krarup H, Jepsen P, Georgsen J, et al
    Mortality in patients with chronic and cleared hepatitis C viral infection: A nationwide cohort study.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
21. MUELLER M , Spangenberg HC, Kersting N, Altay T, et al
    Virus-specific CD4+ T cell responses in chronic HCV infection in blood and liver identified by antigen-specific upregulation of CD154.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
22. SHOUVAL D
    The impact of ribavirin treatment on spermatogenesis in patients with chronic hepatitis C.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
23. PAWLOTSKY JM
    More sensitive hepatitis C virus RNA detection: What for?
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
24. HOFER H , Donnerer J, Sator K, Staufer K, et al
    Seminal fluid ribavirin level and functional semen parameters in patients with chronic hepatitis C on antiviral combination therapy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
25. SARRAZIN C , Shiffman ML, Hadziyannis SJ, Lin A, et al
    Definition of rapid virologic response with a highly sensitive real-time PCR-based HCV RNA assay in peginterferon alfa-2a plus ribavirin response-guided therapy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
26. SOKAL EM , Bourgois A, Stephenne X, Silveira T, et al
    Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
27. NEUMANN UP , Biermer M, Eurich D, Neuhaus P, et al
    Successful prevention of hepatitis C virus (HCV) liver graft reinfection by silibinin mono-therapy.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
28. CLEMENT S , Pascarella S, Conzelmann S, Gonelle-Gispert C, et al
    The hepatitis C virus core protein indirectly induces alpha-smooth muscle actin expression in hepatic stellate cells via interleukin-8.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
29. CARDOSO AC , Moucari R, Figueiredo-Mendes C, Ripault MP, et al
    Impact of peginterferon and ribavirin therapy on hepatocellular carcinoma: Incidence and survival in hepatitis C patients with advanced fibrosis.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
30. FUKUHARA T , Taketomi A, Okano S, Ikegami T, et al
    Mutations in hepatitis C virus genotype 1b and the sensitivity of interferon-ribavirin therapy after liver transplantation.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
31. BEAUVILLAIN C , Meloni F, Sirard JC, Blanchard S, et al
    The scavenger receptors SRA-1 and SREC-I cooperate with TLR2 in the recognition of the hepatitis C virus non-structural protein 3 by dendritic cells.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2010
32. ROCHE B , Samuel D
    Are viral or host factors predictive of response to interferon-ribavirin in transplant patients with hepatitis C?
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
33. FORNS X , Bruix J
    Treating hepatitis C in patients with cirrhosis: The effort is worth it.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
34. WIRTH S , Ribes-Koninckx C, Calzado MA, Bortolotti F, et al
    High sustained virologic response rates in children with chronic hepatitis C receiving peginterferon alfa-2b plus ribavirin.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
35. SHOUVAL D
    Focus.
    J Hepatol. 2010;52:145-6.
    PubMed     Text format     Related articles   
    
    
    January 2010
36. ASSELAH T
    Genetic polymorphism and response to treatment in chronic hepatitis C: The future of personalized medicine.
    J Hepatol. 2010.
    PubMed     Text format     Related articles    Abstract available
    
    
    
37. ALISI A , Comparcola D, Nobili V
    Treatment of chronic hepatitis C in children: Is it necessary and, if so, in whom?
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    
38. BENGSCH B , Thimme R
    Ribavirin ante portas: Uptake transporters into hepatocytes dissected.
    J Hepatol. 2010.
    PubMed     Text format     Related articles   
    
    
    December 2009
39. CLAASSEN MA , de Knegt RJ, Tilanus HW, Janssen HL, et al
    Abundant numbers of regulatory T cells localize to the liver of chronic hepatitis C infected patients and limit the extent of fibrosis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
40. LISMAN T , Bakhtiari K, Pereboom IT, Hendriks HG, et al
    Normal to increased thrombin generation in patients undergoing liver transplantation despite prolonged conventional coagulation tests.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
41. CROTTA S , Brazzoli M, Piccioli D, Valiante NM, et al
    Hepatitis C virions subvert natural killer cell activation to generate a cytokine environment permissive for infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
42. DAI CY , Ho CK, Huang JF, Hsieh MY, et al
    Hepatitis C virus viremia and low platelet count: A study in a hepatitis B & C endemic area in Taiwan.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    November 2009
43. JOUAN L , Melancon P, Rodrigue-Gervais IG, Raymond VA, et al
    Distinct antiviral signaling pathways in primary human hepatocytes and their differential disruption by HCV NS3 protease.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
44. GRUNHAGE F , Nattermann J, Gressner OA, Wasmuth HE, et al
    Lower copy numbers of the chemokine CCL3L1 gene in patients with chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
45. CASTERA L , Sebastiani G, Le Bail B, de Ledinghen V, et al
    Prospective comparison of two algorithms combining non-invasive methods for staging liver fibrosis in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
46. GRASSO A
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: A clarification.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
47. DONATO C , Cingolani A, Pinnetti C, De Luca A, et al
    Insulin resistance and HCV virologic response to peg-interferons (Peg-IFN) with ribavirin (RBV) in HIV/HCV co-infected patients.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
48. WU KT , Yang JF, Chuang WL, Yu ML, et al
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin: Some issues.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    October 2009
49. MARCELLIN P , Gish RG, Gitlin N, Heise J, et al
    Safety and efficacy of viramidine versus ribavirin in ViSER2: Randomized, double-blind study in therapy-naive hepatitis C patients.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
50. NAKAMOTO S , Imazeki F, Fukai K, Fujiwara K, et al
    Association between mutations in the core region of hepatitis C virus genotype 1 and hepatocellular carcinoma development.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
51. MORENO C , Deltenre P, Pawlotsky JM, Henrion J, et al
    Shortened treatment duration in treatment-naive genotype 1 HCV patients with rapid virological response: A meta-analysis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
52. SCHAFER A , Scheurlen M, Seufert J, Keicher C, et al
    Platelet serotonin (5-HT) levels in interferon-treated patients with hepatitis C and its possible association with interferon-induced depression.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
53. COBBOLD JF , Patel JH, Goldin RD, North BV, et al
    Hepatic lipid profiling in chronic hepatitis C: An in vitro and in vivo proton magnetic resonance spectroscopy study.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
54. RUMI MG
    Pegylated interferon alpha2b versus pegylated interferon alpha2a for chronic hepatitis C: The unreached goal of superiority.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
55. ZEUZEM S
    Forewarned is forearmed.
    J Hepatol. 2009;51:626-7.
    PubMed     Text format     Related articles   
    
    
    September 2009
56. HIRAGA N , Imamura M, Hatakeyama T, Kitamura S, et al
    Absence of viral interference and different susceptibility to interferon between hepatitis B virus and hepatitis C virus in human hepatocyte chimeric mice.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
57. SAMRI A , Roque-Afonso AM, Beran O, Tateo M, et al
    Preservation of immune function and anti-hepatitis C virus (HCV) immune responses after liver transplantation in HIV-HCV coinfected patients (ANRS-HC08 "THEVIC" trial).
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
58. HOUGHTON M
    The long and winding road leading to the identification of the hepatitis C virus.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    August 2009
59. DE NICOLA S , Aghemo A, Rumi MG, Colombo M, et al
    HCV genotype 3: An independent predictor of fibrosis progression in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
60. CERNY A
    Hepatitis C after simultaneous liver-kidney transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
61. PARK CY , Choi SH, Kang SM, Kang JI, et al
    Nonstructural 5A protein activates beta-catenin signaling cascades: Implication of hepatitis C virus-induced liver pathogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
62. GIRELLI D , Pasino M, Goodnough JB, Nemeth E, et al
    Reduced serum hepcidin levels in patients with chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
63. CARRION JA , Navasa M, Forns X
    Antiviral therapy in HCV-infected cirrhotic patients awaiting liver transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    July 2009
64. WANG B , Trippler M, Pei R, Lu M, et al
    Toll-like receptor activated human and murine hepatic stellate cells are potent regulators of hepatitis c virus replication.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
65. GRASSO A , Malfatti F, Leo PD, Martines H, et al
    Insulin resistance predicts rapid virological response in non-diabetic, non-cirrhotic genotype 1 HCV patients treated with peginterferon alpha-2b plus ribavirin.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
66. REESINK HW , Weegink CJ
    New hope for a cure for chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
67. GREBELY J , Thomas DL, Dore GJ
    HCV reinfection studies and the door to vaccine development.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
68. CAMMA C , Cabibbo G, Bronte F, Enea M, et al
    Retreatment with pegylated interferon plus ribavirin of chronic hepatitis C non-responders to interferon plus ribavirin: A meta-analysis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
69. BALFE P , McKeating JA
    The complexities of hepatitis C virus entry.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
70. WEILAND O
    What offers the best prediction of sustained virologic response during combination therapy with interferon and ribavirin: viral dynamics, viral levels at certain time points, or a combination of both?
    J Hepatol. 2009;51:4-7.
    PubMed     Text format     Related articles   
    
    
    June 2009
71. NIEMCZYK M , Krawczyk M, Paczek L
    Antiviral therapy preceding liver transplantation in HCV cirrhosis - Still too many doubts.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
72. MANSILLA C , Gorraiz M, Martinez M, Casares N, et al
    Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
73. LI Y , Chang M, Abar O, Garcia V, et al
    Multiple variants in toll-like receptor 4 gene modulate risk of liver fibrosis in Caucasians with chronic hepatitis C infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
74. VAN DE LAAR TJ , Molenkamp R, van den Berg C, Schinkel J, et al
    Frequent HCV reinfection and superinfection in a cohort of injecting drug users in Amsterdam.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
75. VAN WAGNER LB , Baker T, Ahya SN, Norvell JP, et al
    Outcomes of patients with hepatitis C undergoing simultaneous liver-kidney transplantation.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
76. BOCHUD PY , Cai T, Overbeck K, Bochud M, et al
    Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
77. EYRE NS , Phillips RJ, Bowden S, Yip E, et al
    Hepatitis B virus and hepatitis C virus interaction in Huh-7 cells.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    May 2009
78. BARTOSCH B , Thimme R, Blum HE, Zoulim F, et al
    Hepatitis C virus-induced hepatocarcinogenesis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
79. PFEFFER S , Baumert TF
    Unravelling the importance of microRNAs during hepatitis C virus infection in the human liver.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    April 2009
80. COOPER C , Lawitz EJ, Ghali P, Rodriguez-Torres M, et al
    Evaluation of VCH-759 monotherapy in hepatitis C infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
81. WEGERT M , Monica NL, Tripodi M, Adler G, et al
    Impaired interferon type I signalling in the liver modulates the hepatic acute phase response in hepatitis C virus transgenic mice.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
82. ZHANG YL , Guo YJ, Bin Li, Sun SH, et al
    Hepatitis C virus single-stranded RNA induces innate immunity via Toll-like receptor 7.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    March 2009
83. FERRI S , Muratori L, Quarneti C, Muratori P, et al
    Clinical features and effect of antiviral therapy on anti-liver/kindey microsomal antibody type 1 positive chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
84. RAIMONDI S , Bruno S, Mondelli MU, Maisonneuve P, et al
    Hepatitis C virus genotype 1b as a risk factor for hepatocellular carcinoma development: A meta-analysis.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
85. DE VOS R , Verslype C, Depla E, Fevery J, et al
    WITHDRAWN: Ultrastructural visualization of hepatitis C virus components in human and primate liver biopsies.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
86. BARTOSCH B
    Hepatitis C virus and its complex interplay with the hepatic glucose and lipid metabolism.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
87. NEGRO F
    Correction of insulin resistance in chronic hepatitis C patients not responding to the standard of care: More questions than answers.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
88. SERFATY L , Fartoux L, Poupon R
    Pioglitazone as adjuvant therapy in chronic hepatitis C: Sequential rather than concomitant administration with pegylated interferon and ribavirin?
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
89. NEUMANN AU , Pianko S, Zeuzem S, Yoshida EM, et al
    Positive and negative prediction of sustained virologic response at weeks 2 and 4 of treatment with albinterferon alfa-2b or peginterferon alfa-2a in treatment-naive patients with genotype 1, chronic hepatitis C.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    February 2009
90. KASAI D , Adachi T, Deng L, Nagano-Fujii M, et al
    HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
91. VLIEGEN I , Paeshuyse J, Burghgraeve TD, Lehman LS, et al
    Substituted imidazopyridines as potent inhibitors of HCV replication.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
92. DIONISIO N , Garcia-Mediavilla MV, Sanchez-Campos S, Majano PL, et al
    Hepatitis C virus NS5A and core proteins induce oxidative stress-mediated calcium signalling alterations in hepatocytes.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
93. HUANG YH , Wu JC, Peng WL, Huo TI, et al
    Generation of cytotoxicity against hepatitis delta virus genotypes and quasispecies by epitope modification.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
94. KIM KA , Lin W, Tai AW, Shao RX, et al
    Hepatic SOCS3 expression is strongly associated with non-response to therapy and race in HCV and HCV/HIV infection.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
95. ROCHE B , Samuel D
    Antiviral therapy in HCV-infected cirrhotics awaiting liver transplantation: A costly strategy for mixed virological results.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
96. SULKOWSKI M
    Hepatocellular carcinoma in HIV-infected patients comes of age: The convergence of epidemiology and treatment effectiveness.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
97. DAI CY , Huang JF, Hsieh MY, Hou NJ, et al
    Insulin resistance predicts response to peginterferon-alpha/ribavirin combination therapy in chronic hepatitis C patients.
    J Hepatol. 2009.
    PubMed     Text format     Related articles    Abstract available
    
    
    
98. CAMMA C , Petta S
    Insulin resistance in HCV mono-infected and in HIV/HCV co-infected patients: Looking to the future.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    
99. MARRERO JA
    Modern diagnosis of hepatocellular carcinoma: Utilization of liver biopsy and genomic markers.
    J Hepatol. 2009.
    PubMed     Text format     Related articles   
    
    
    January 2009
100. SAUTER D , Himmelsbach K, Kriegs M, Yepes MC, et al
     Localization determines function: N-terminally truncated NS5A fragments accumulate in the nucleus and impair HCV replication.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
101. WESESLINDTNER L , Neumann-Haefelin C, Viazov S, Haberstroh A, et al
     Acute infection with a single hepatitis C virus strain in dialysis patients: Analysis of adaptive immune response and viral variability.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
102. KUMADA T , Toyoda H, Kiriyama S, Sone Y, et al
     Incidence of hepatocellular carcinoma in hepatitis C carriers with normal alanine aminotransferase levels.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
103. SALMON-CERON D , Rosenthal E, Lewden C, Bouteloup V, et al
     Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalite 2005 study.
     J Hepatol. 2009.
     PubMed     Text format     Related articles    Abstract available
     
     
     
104. BEDOSSA P , Carrat F
     Liver biopsy: the best, not the gold standard.
     J Hepatol. 2009;50:1-3.
     PubMed     Text format     Related articles   
     
     
     
105. MEHTA SH , Lau B, Afdhal NH, Thomas DL, et al
     Exceeding the limits of liver histology markers.
     J Hepatol. 2009;50:36-41.
     PubMed     Text format     Related articles    Abstract available
     
     
     December 2008
106. CARRION JA , Martinez-Bauer E, Crespo G, Ramirez S, et al
     Antiviral therapy increases the risk of bacterial infections in HCV-infected cirrhotic patients awaiting liver transplantation: A retrospective study.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
107. MERCHANTE N , de Los Santos-Gil I, Merino D, Gonzalez-Serrano M, et al
     Insulin resistance is not a relevant predictor of sustained virological response to pegylated interferon plus ribavirin in HIV/HCV co-infected patients.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
108. KIM SI , Shin D, Lee H, Ahn BY, et al
     Targeted delivery of siRNA against hepatitis C virus by apolipoprotein A-I-bound cationic liposomes.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
109. PIETSCHMANN T
     Regulation of hepatitis C virus replication by microRNAs.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
110. HUANG JF , Dai CY, Yu ML, Shin SJ, et al
     Serum retinol-binding protein 4 is inversely correlated with disease severity of chronic hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
111. CHOLONGITAS E , Manousou P, Samonakis D, Burroughs AK, et al
     Progression of HCV infection in patients with chronic kidney disease.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
112. MARTIN P , Fabrizi F
     Progression of HCV infection in patients with chronic kidney disease: Reply.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
113. GOZLAN J , Lacombe K, Gault E, Raguin G, et al
     Complete cure of HBV-HDV co-infection after 24weeks of combination therapy with pegylated interferon and ribavirin in a patient co-infected with HBV/HCV/HDV/HIV.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
114. BERRES ML , Papen S, Pauels K, Schmitz P, et al
     A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
115. GIANNINI EG , Savarino V
     HCV and fat: Something is missing.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
116. DAI CY , Chuang WL, Ho CK, Yu ML, et al
     Hepatitis C viremia and serum lipid levels: A clue from an epidemiology study.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
117. REDDY KR , Nelson DR, Zeuzem S
     Ribavirin: Current role in the optimal clinical management of chronic hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
118. TAI AW , Chung RT
     Treatment failure in hepatitis C: Mechanisms of non-response.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
119. MICHALAK TI , Pham TN
     Anti-HCV core antibody: A potential new marker of occult and otherwise serologically silent HCV infection.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     November 2008
120. VARCHETTA S , Oliviero B, Francesca Donato M, Agnelli F, et al
     Prospective study of natural killer cell phenotype in recurrent hepatitis C virus infection following liver transplantation.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
121. MIHM U , Ackermann O, Welsch C, Herrmann E, et al
     Clinical relevance of the 2'-5'-oligoadenylate synthetase/RNase L system for treatment response in chronic hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
122. WEDEMEYER I , Bechmann LP, Odenthal M, Jochum C, et al
     Adiponectin inhibits steatotic CD95/Fas up-regulation by hepatocytes: Therapeutic implications for hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
123. SCHUSTER C , Baumert TF
     EWI-2wint - A host cell factor inhibiting hepatitis C virus entry.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
124. THOMPSON A , Patel K, Tillman H, McHutchison JG, et al
     Directly acting antivirals for the treatment of patients with hepatitis C infection: A clinical development update addressing key future challenges.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
125. QUIROGA JA , Castillo I, Llorente S, Bartolome J, et al
     Identification of serologically silent occult hepatitis C virus infection by detecting immunoglobulin G antibody to a dominant HCV core peptide epitope.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
126. KIM E , Li K, Lieu C, Tong S, et al
     Expression of apolipoprotein C-IV is regulated by Ku antigen/peroxisome proliferator-activated receptor gamma complex and correlates with liver steatosis.
     J Hepatol. 2008;49:787-98.
     PubMed     Text format     Related articles    Abstract available
     
     
     October 2008
127. EUROPEAN ASSOCIATION FOR THE S
     EASL Clinical Practice Guidelines: Management of chronic hepatitis B.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
128. CASTERA L , Bail BL, Roudot-Thoraval F, Bernard PH, et al
     Early detection in routine clinical practice of cirrhosis and oesophageal varices in chronic hepatitis C: Comparison of transient elastography (FibroScan) with standard laboratory tests and non-invasive scores.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
129. FORNS X
     Role of nosocomial hospital transmission in acute hepatitis C: Reply.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
130. MORIN T , Pariente A, Cadranel JF, Denis J, et al
     Role of nosocomial hospital transmission in acute hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
131. HASSAN MM , Spitz MR, Thomas MB, Curley SA, et al
     The association of family history of liver cancer with hepatocellular carcinoma: A case-control study in the United States.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
132. MACIAS J , Recio E, Vispo E, Rivero A, et al
     Application of transient elastometry to differentiate mild from moderate to severe liver fibrosis in HIV/HCV co-infected patients.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     September 2008
133. ALBERT ML , Decalf J, Pol S
     Plasmacytoid dendritic cells move down on the list of suspects: In search of the immune pathogenesis of chronic hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
134. TEUBER G , Schafer A, Rimpel J, Paul K, et al
     Deterioration of health-related quality of life and fatigue in patients with chronic hepatitis C: Association with demographic factors, inflammatory activity, and degree of fibrosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
135. TSAI YH , Kuang WF, Lu TY, Kao JH, et al
     The non-structural 5A protein of hepatitis C virus exhibits genotypic differences in interferon antagonism.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
136. GRIFFIN S , Trowbridge R, Thommes P, Parry N, et al
     Chimeric GB virus B genomes containing hepatitis C virus p7 are infectious in vivo.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     August 2008
137. WHITE DL , Ratziu V, El-Serag HB
     Hepatitis C infection and risk of diabetes: A systematic review and meta-analysis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
138. RAIMONDO G , Saitta C
     Treatment of the hepatitis B virus and hepatitis C virus co-infection: Still a challenge for the hepatologist.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
139. SILVA MO
     Compare trial: updated data.
     J Hepatol. 2008;49:288-9.
     PubMed     Text format     Related articles   
     
     
     July 2008
140. KAU A , Vermehren J, Sarrazin C
     Treatment predictors of a sustained virologic response in hepatitis B and C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
141. PAGGI S , Colli A, Fraquelli M, Vigano M, et al
     A non-invasive algorithm accurately predicts advanced fibrosis in hepatitis C: A comparison using histology with internal-external validation.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
142. LA MURA V , Renzo AD, Perna F, D'Agostino D, et al
     Antiviral therapy after complete response to chemotherapy could be efficacious in HCV-positive non-Hodgkin's lymphoma.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
143. SELZNER N , McGilvray I
     Can genetic variations predict HCV treatment outcomes?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
144. GARATTINI S
     Is there discrimination in access to therapy for HCV patients?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
145. SANTANTONIO T , Wiegand J, Tilman Gerlach J
     Acute hepatitis C: Current status and remaining challenges.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
146. PIROTH L , Carrat F, Larrat S, Goderel I, et al
     Prevalence and impact of GBV-C, SEN-V and HBV occult infections in HIV-HCV co-infected patients on HCV therapy.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
147. MCPHERSON S , Jonsson JR, Barrie HD, O'Rourke P, et al
     Investigation of the role of SREBP-1c in the pathogenesis of HCV-related steatosis.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
148. GHEORGHE L , Iacob S, Csiki IE
     Prevalence of hepatitis C in Romania: Different from European rates?
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
149. QUER J , Esteban JI, Sauleda S
     Prevalence of hepatitis C in Romania: Different from European rates? Reply.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
150. MURAKAMI Y , Aly HH, Tajima A, Inoue I, et al
     Regulation of the hepatitis C virus genome replication by miR-199a.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
151. TOGASHI H , Hashimoto C, Yokozawa J, Suzuki A, et al
     What can be revealed by extending the sensitivity of HBsAg detection to below the present limit?
     J Hepatol. 2008;49:17-24.
     PubMed     Text format     Related articles    Abstract available
     
     
     June 2008
152. RENDINA M , Schena A, Schena FP, Francavilla A, et al
     Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon alpha-2a: Reply.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
153. SPERL J , Petrasek J, Spicak J, Viklicky O, et al
     Acute rejection of non-functional allograft in kidney transplant recipients with hepatitis C treated with peginterferon-alpha2a.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
154. MATTHEWS GV , Grebely J, Dore GJ
     The role of re-infection in determining rates of spontaneous clearance after hepatitis C exposure.
     J Hepatol. 2008.
     PubMed     Text format     Related articles   
     
     
     
155. MARTIN P , Fabrizi F
     Hepatitis C virus and kidney disease.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
156. HALANGK J , Sarrazin C, Neumann K, Puhl G, et al
     Evaluation of complement factor 5 variants as genetic risk factors for the development of advanced fibrosis in chronic hepatitis C infection.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
157. BURTON JR JR , Klarquist J, Im K, Smyk-Pearson S, et al
     Prospective analysis of effector and regulatory CD4(+) T cells in chronic HCV patients undergoing combination antiviral therapy.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     
158. FUJITA N , Sugimoto R, Motonishi S, Tomosugi N, et al
     Patients with chronic hepatitis C achieving a sustained virological response to peginterferon and ribavirin therapy recover from impaired hepcidin secretion.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
159. CHEN W , Wong T, Tomlinson G, Krahn M, et al
     Prevalence and predictors of obesity among individuals with positive hepatitis C antibody in a tertiary referral clinic.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
160. MORGAN TR , Lambrecht RW, Bonkovsky HL, Chung RT, et al
     DNA polymorphisms and response to treatment in patients with chronic hepatitis C: Results from the HALT-C trial.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
161. LETTMEIER B , Muhlberger N, Schwarzer R, Sroczynski G, et al
     Market uptake of new antiviral drugs for the treatment of hepatitis C.
     J Hepatol. 2008.
     PubMed     Text format     Related articles    Abstract available
     
     
     May 2008
162. RIBES J , Cleries R, Esteban L, Moreno V, et al
     The influence of alcohol consumption and hepatitis B and C infections on the risk of liver cancer in Europe.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     
     
163. CASTERA L , Forns X, Alberti A
     Non-invasive evaluation of liver fibrosis using transient elastography.
     J Hepatol. 2008;48:835-47.
     PubMed     Text format     Related articles    Abstract available
     
     
     
164. SEBASTIANI G , Alberti A
     Implementing non-invasive markers for liver fibrosis in clinical practice.
     J Hepatol. 2008;48:880-1.
     PubMed     Text format     Related articles   
     
     
     February 2008
165. SAMUEL D , Weber R, Stock P, Duclos-Vallee JC, et al
     Are HIV-infected patients candidates for liver transplantation?
     J Hepatol. 2008;.
     PubMed     Text format     Related articles   
     
     
     January 2008
166. NEWELL P , Villanueva A, Friedman SL, Koike K, et al
     Experimental models of hepatocellular carcinoma.
     J Hepatol. 2008;.
     PubMed     Text format     Related articles    Abstract available
     
     

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: